Squawk Pod - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Squawk Pod — Business
Squawk Pod

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.

Copyright: © 2024 CNBC

Latest Episodes:

Special Report | Markets in Turmoil: California Reopening & Moderna Vaccine May 08, 2020

Show notes

Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Goldman’s Former Head Lloyd Blankfein: Poverty & GDP Are Also Health Issues May 07, 2020

Show notes

Lloyd Blankfein, former Goldman Sachs CEO and famed risk manager, discusses reopening economies to spare Americans further economic--and possibly physical--damage, and he shares lessons learned from the last financial crisis. United States Secretary of State Mike Pompeo explains Covid diplomacy as the U.S. looks to China for help in ending the global pandemic.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Special Report | Markets in Turmoil: Amazon Death & Child Illness May 07, 2020

Show notes

Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Covid’s Mutations & Treatments; The (New) Office with Architectural Digest May 06, 2020

Show notes

A new report suggests that Covid-19 has mutated into a new, strong strain; former head of the FDA Dr. Scott Gottlieb explains the relationship between virus mutations and increased infectiousness. Adaptive Biotechnologies CEO explains how his company is working on developing coronavirus treatments using human immune systems. Plus, office culture as we know it may change once the pandemic subsides. Features Director at Architectural Digest Sam Cochran discusses building a new normal in the workplace.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Special Report | Markets in Turmoil: Pfizer Vaccine & Food Prices May 06, 2020

Show notes

Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Doordash CEO & the Essential Gig Economy; Reddit Co-Founder; WeWork Saga Continued May 05, 2020

Show notes

United Airlines is warning employees about job cuts after it accepted federal aid to avoid layoffs. CNBC’s Phil LeBeau reveals that this move may be just the beginning of Covid’s impact on the airline industry. Tech players big and small may have the ability to trace cases of coronavirus, but will they get permission? Reddit co-founder and venture capitalist Alexis Ohanian explains the challenge ahead for technologists as Americans weigh personal privacy against public health. Food delivery platform Doordash is teaming up with Pennsylvania’s Attorney General to keep essential delivery workers safe. The company’s CEO and the PA AG laud gig economy workers on the front lines of the pandemic. WeWork’s Adam Neumann is making headlines again; CNBC’s Deirdre Bosa discusses the latest chapter--and lawsuit--in the co-working intrigue. Plus, at-home haircuts, fridge staples’ rising costs, and social media tensions between China and the United States.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Special Report | Markets in Turmoil: Airlines & Future of Sports May 05, 2020

Show notes

Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Warren Buffett: “Nothing can stop America” May 04, 2020

Show notes

Berkshire Hathaway’s 2020 annual shareholder meeting, the “Woodstock for Capitalists” -- which allows the company’s 40,000+ investors to question the Oracle of Omaha directly -- was hosted virtually for the first time ever. The four-hour live-streamed presentation and Q&A gave insight into Warren Buffett’s investing mindset amid the coronavirus crisis. Becky Quick joins the podcast with exclusive insight and highlights from the meeting. Chief Economic Adviser of Allianz, Mohamed El-Erian, discusses Warren Buffett’s take on the markets and the impact of the Fed’s emergency response to the coronavirus crisis. Plus, words of hope from Apple CEO Tim Cook to the class of 2020.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Special Report | Markets in Turmoil: Gilead & COVID-19 Testing May 02, 2020

Show notes

Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Gilead’s Remdesivir, the Drug that Could Treat Covid-19 May 01, 2020

Show notes

Gilead CEO Daniel O’Day shares details of Remdesivir’s two positive trials against Covid-19. He explains collaboration among global drugmakers, the process of finding a treatment for coronavirus, and worldwide, equitable distribution of the drug once it’s developed. CNBC’s Senior Health Science Reporter Meg Tirrell traces the history of Remdesivir, as well as the world’s response to pandemics in the past. In a conversation exclusive to Squawk Pod, Tirrell tracks the drugmakers still in the race for a Covid vaccine and treatment, and she explains covering the pandemic accurately amid rapidly evolving headlines.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Related Podcasts